ArticleJournal of thoracic disease2025
Evaluation of 1.1 mm ultrathin cryobiopsy through a guide sheath for sampling of peripheral pulmonary lesions.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Feasibility of direct cryobiopsy specimen retrieval through the working channel of an ultrathin bronchoscope-a retrospective study of single institute.Journal of thoracic disease · 2026Article
- Cryoprobe-Assisted Bronchoscopy: Noninvasive Route to Definitive Diagnosis of Pulmonary Lymphomatoid Granulomatosis.Case reports in pulmonology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cryobiopsy provides a large amount of specimen with minimal crush artifact, but carries the risk of serious complications such as severe bleeding or pneumothorax. Transbronchial 1.1 mm ultrathin cryobiopsy can be performed through a guide sheath, potentially enabling repeated biopsies from the same location and reducing bleeding complications. This study retrospectively assessed the safety and efficacy of ultrathin cryobiopsy with a 1.1 mm cryoprobe, which can pass through a large guide sheath under radial endobronchial ultrasound (R-EBUS) guidance. Methods: This retrospective observational study evaluated 1.1 mm ultrathin cryobiopsy through a guide sheath (GS-UTCB) for peripheral pulmonary lesions (PPLs), including solitary lesions, pulmonary infiltration, and ground-glass opacity. We compared bronchoscopic parameters between GS-UTCB and conventional endobronchial ultrasound with a guide sheath (EBUS-GS) procedures. In the GS-UTCB group, we analyzed the diagnostic yield of both the 1.1 mm cryoprobe and standard forceps biopsy. Additionally, tissue area and crush artifacts were evaluated for each device. Results: Between January 2022 and May 2023, 109 patients underwent bronchoscopy; 13 patients received GS-UTCB and 34 received EBUS-GS. The procedure time of the GS-UTCB group was significantly longer than that of the EBUS-GS group (P=0.04). Mild bleeding was significantly more frequent with GS-UTCB group, but there was no significant difference in moderate bleeding. There were no severe or life-threatening complications. In the GS-UTCB group, the diagnostic yield reached 92.3% in total, with 1.1 mm cryoprobe biopsy achieving 84.6% and standard forceps biopsy achieving 69.2%. Tissue area from 1.1 mm cryoprobe specimens was significantly larger than standard forceps (P<0.001), with minimal crush artifacts. Conclusions: GS-UTCB represents a safe and effective method for sampling of various types of PPLs, demonstrating the potential to complement conventional forceps biopsy with superior tissue quality and diagnostic capability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.